Protein biomarker for pancreatic ductal adenocarcinoma

被引:4
|
作者
Burki, Talha K.
机构
来源
LANCET ONCOLOGY | 2017年 / 18卷 / 09期
关键词
D O I
10.1016/S1470-2045(17)30564-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E511 / E511
页数:1
相关论文
共 50 条
  • [1] AGRIN PROTEIN AS A MOLECULAR PROGNOSTIC BIOMARKER IN PANCREATIC DUCTAL ADENOCARCINOMA
    Morao, Barbara
    Santos, Maria Pia Costa
    Fidalgo, Catarina
    Faria, Ana
    Maio, Rui
    Bastos, Nuno
    Cravo, Marilia
    Melo, Sonia
    GASTROENTEROLOGY, 2021, 160 (06) : S297 - S297
  • [2] Biomarker detection in pancreatic ductal adenocarcinoma
    Klett, H.
    Klose, M.
    Kowar, S.
    Bronsert, P.
    Kuesters, S.
    Werner, M.
    Christoph, P.
    Busch, H.
    Boerries, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S177 - S178
  • [3] Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
    Kim, Hongbeom
    Kang, Kyung Nam
    Shin, Yong Sung
    Byun, Yoonhyeong
    Han, Youngmin
    Kwon, Wooil
    Kim, Chul Woo
    Jang, Jin-Young
    CANCERS, 2020, 12 (06)
  • [4] C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients
    Bonazzi, Vanessa F.
    Aoude, Lauren G.
    Brosda, Sandra
    Bradford, Julia J.
    Lonie, James M.
    Loffler, Kelly A.
    Gartside, Michael G.
    Patel, Kalpana
    Mukhopadhyay, Pamela
    Keane, Colm
    Gebski, Val
    Kench, James G.
    Goldstein, David
    Waddell, Nicola
    Barbour, Andrew P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2025, 21 (01) : 77 - 86
  • [5] Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma
    Schaefer, Claus
    Seeliger, Hendrik
    Bader, Dominik C.
    Assmann, Gerald
    Buchner, Denise
    Guo, Yang
    Ziesch, Andreas
    Palagyi, Andreas
    Ochs, Stephanie
    Laubender, Ruediger P.
    Jung, Andreas
    De Toni, Enrico N.
    Kirchner, Thomas
    Goeke, Burkhard
    Bruns, Christiane
    Gallmeier, Eike
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (08) : 1776 - 1791
  • [7] MRGBP as a potential biomarker for the malignancy of pancreatic ductal adenocarcinoma
    Ding, Feng
    Zhang, Shuang
    Gao, Shaoyang
    Shang, Jian
    Li, Yanxia
    Cui, Ning
    Zhao, Qiu
    ONCOTARGET, 2017, 8 (38) : 64224 - 64236
  • [8] Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC).
    Krantz, Benjamin A.
    Tsui, Dana
    Lowery, Maeve Aine
    Capanu, Marinela
    Yu, Kenneth H.
    Kelsen, David Paul
    Gedvilaite, Erika
    Zhang, Liguo
    Selcuklu, S. Duygu
    You, Daoqi
    Pernicka, Jennifer S. Golia
    Do, Richard K. G.
    Iacobuzio-Donahue, Christine A.
    O'Reilly, Eileen Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
    Makler, Amy
    Narayanan, Ramaswamy
    Asghar, Waseem
    BIOSENSORS-BASEL, 2022, 12 (10):
  • [10] Tissue transglutaminase II: A biomarker of pancreatic ductal adenocarcinoma
    Yang, GY
    Dilworth, HP
    Ashfaq, R
    Hruban, RH
    Maitra, A
    MODERN PATHOLOGY, 2005, 18 : 290A - 290A